Ceftriaxone Sodium Hydrate Injection 1g

Adult administration

For adults and children over 12 years, 1-2g (potency) of ceftriaxone is administered intravenously or intramuscularly once daily. For infections caused by severe pathogens or pathogens showing moderate sensitivity, the dosage can be increased to 4g (potency) once daily. Elderly patients should follow the dosage regimen for adults without any changes. For the treatment of gonorrhea, a single intramuscular injection of 250mg (potency) is recommended. For pre- and post-operative infections

Child administration

In newborns (within 14 days of birth), administer 20-50mg (potency) per kg of body weight once daily, not exceeding 50mg (potency). For infants and children (15 days to 12 years old), administer 20-

This drug must not be mixed or administered simultaneously with solutions containing calcium or other medications. Especially in newborns, the combination of this drug and calcium can precipitate serious side effects, so it must never be used. Patients with allergies to this drug or its components, or with hypersensitivity to penicillins or cephalosporins, should not use this drug. Furthermore, it should not be used in premature infants, those with jaundice, or newborns expected to have bilirubin binding disorders. Patients with a history of drug allergies, or those with bronchial asthma, skin rashes, or other allergic symptoms that occur easily, should use this drug with caution. Patients with severely impaired kidney function will need dose adjustments. While using this drug, side effects such as diarrhea, rashes, liver dysfunction, changes in blood cell counts, headaches, and dizziness may occur, so any unusual symptoms should be reported to medical personnel immediately. Rarely, severe allergic reactions or neurological disturbances have been reported, so caution is required. Regular monitoring of liver and kidney function and blood tests during administration is important. This drug can cause dizziness, so care is needed when driving or operating machinery. Pregnant or nursing women should use this drug cautiously and only after consulting with a doctor, as it may affect the fetus or newborn. Elderly patients may experience side effects more easily due to decreased physical function, so dosage and administration intervals should be adjusted, and careful observation is required. This drug can affect certain test results, so patients should inform healthcare professionals about its use during tests. Finally, this drug must always be used according to a doctor's prescription and instructions, and patients should not discontinue or change the dosage on their own.

Serious side effects

Urticaria, severe swelling (edema), cold sweat, difficulty breathing, anaphylaxis, anaphylactoid reactions, severe allergic reactions, severe skin adverse reactions, liver abnormalities (jaundice), serious neurological symptoms, acute renal failure, severe edema or urinary abnormalities, encephalopathy, seizures, confusion, visual disturbances, paralysis, asthma attacks, respiratory abnormalities accompanied by cough and fever, shock

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• increased liver enzymes
• dizziness
• nausea
• vomiting
• loose stools

This drug should be stored in a sealed container to prevent air exposure, and it is safe to store it at room temperature between 1°C and 30°C. Proper storage will maintain the drug's efficacy and prevent deterioration.

Appearance

An injection in a colorless, transparent vial filled with a white to light yellow crystalline powder

Package unit

1, 10 vials